TRAUMAGEL™ is a hemostatic device with a prospective indication for temporary use to control external traumatic bleeding not amenable to tourniquet application.

Intended applications of TRAUMAGEL™ include military combat use and civilian emergency medical services use. TRAUMAGEL™ is currently undergoing exploratory proof of concept testing by Cresilon.

For demonstration purposes only. TRAUMAGEL™ is a hemostatic device under investigation by Cresilon for use in humans. It is not FDA approved or CE marked at this time.